-
Locked Data M_2_9_1
Number of individuals linked to MOUD following opioid overdose (Medicaid) -
Locked Data M_2_7_3_a
Number of individuals who received naltrexone (injectable only) for treatment of OUD that are retained for at least 180 days (Medicaid) -
Locked Data M_2_7_3_b
Number of individuals who receive naltrexone (oral only) for treatment of OUD that are retained at least 180 days (Medicaid) -
Locked Data M_2_7_6
Number of individuals who received buprenorphine for treatment of OUD that are retained at least 180 days (Medicaid) -
Locked Data M_2_7_3
Number of individuals who received naltrexone (combined injectable and oral) for at least 180 days (Medicaid) -
Locked Data M_2_7_4
Number of individuals with who received medication for treatment of OUD that are retained at least 180 days (Medicaid) -
Locked Data M_2_6_3
Number of individuals with OUD who received behavioral health treatment in outpatient settings (Medicaid) -
Locked Data M_2_6_2
Number of individuals with OUD who received behavioral health treatment in intensive outpatient settings (Medicaid) -
Locked Data M_2_6_4
Number of individuals with OUD who received behavioral health treatment in any setting (Medicaid) -
Locked Data M_2_7_1
Number of individuals who received buprenorphine for treatment of opioid use disorder (OUD) that are retained at least 180 days -
Locked Data M_2_6_7
Number of individuals with OUD who received case management and/or peer support (Medicaid) -
Locked Data M_2_6_6
Number of individuals with OUD who received peer support (Medicaid) -
Locked Data M_2_7_5
Person-months in MOUD (Medicaid) -
Locked Data M_2_5_3_a
Number of individuals who received naltrexone (injectable only) for treatment of OUD (Medicaid) -
Locked Data M_2_5_3_b
Number of individuals who received naltrexone (oral only) for treatment of OUD (Medicaid) -
Locked Data M_2_6_1
Number of individuals with OUD who received behavioral health treatment in inpatient settings (Medicaid) -
Locked Data M_2_5_3
Number of individuals who received naltrexone (combined injectable and oral) for treatment of OUD (Medicaid) -
Locked Data M_2_6_5
Number of individuals with OUD who received case management (Medicaid) -
Locked Data M_2_5_1
Number of individuals who received buprenorphine for treatment of OUD (outcome measure for HCS Hypothesis 3) -
Locked Data M_2_7_2
Number of individuals receiving methadone retained at least 180 days (Medicaid)